CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS

Etanercept (ETC), a soluble tumor necrosis factor-α (TNF-α) receptor, was registered for the treatment of spondyloarthritis in the Russian Federation in 2009. By now, results of prolonged treatment with this drug have been obtained in patients with ankylosing spondylitis (AS).Objective: to evaluate...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: O. A. Rumyantseva, A. G. Bochkova, M. M. Urumova, T. V. Dubinina, Sh. F. Erdes
Natura: Artigo
Lingua:Russo
Pubblicazione: IMA-PRESS LLC 2018-05-01
Serie:Научно-практическая ревматология
Soggetti:
etanercept
ankylosing spondylitis
axial spondyloarthritis
remission
Accesso online:https://rsp.mediar-press.net/rsp/article/view/2524
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi